Cancer Policy One year of reducing animal testing in drug development April 24, 2026Vol.52 No.16By Claire Marie Porter
Cancer Policy FDA and CMS announce RAPID coverage pathway aimed at accelerating patient access to some Breakthrough medical devices April 24, 2026Vol.52 No.16
Cancer Policy FDA adds stereotactic breast biopsy needles to the shortage list April 17, 2026Vol.52 No.15By Jacquelyn Cobb
Cancer Policy CMS proposed rule would implement electronic prior authorization requirements for covered drugs in federal health plans April 17, 2026Vol.52 No.15By Jacquelyn Cobb
Cancer Policy At Friends meeting, data quality, modern evidence generation, and early regulatory alignment top the list of “next steps” for external control arms April 17, 2026Vol.52 No.15By Jacquelyn Cobb
Cancer Policy ACIP charter is renewed as meetings remain on indefinite hold April 17, 2026Vol.52 No.15By Jacquelyn Cobb
Cancer Policy FDA issues reminder to sponsors: Disclose clinical trial results April 17, 2026Vol.52 No.15By Jacquelyn Cobb
Cancer Policy Health groups urge Bhattacharya, in his position of acting CDC director, to restore staff in the Office on Smoking and Health April 17, 2026Vol.52 No.15By Jacquelyn Cobb
Cancer Policy President’s budget request would cap indirect costs and fully fund all NIH research projects upfront April 10, 2026Vol.52 No.14By Claire Marie Porter and Jacquelyn Cobb
Cancer Policy CMS proposes rule to update Medicare payments and transparency requirements for hospice care April 10, 2026Vol.52 No.14By Sara Willa Ernst
